Endpoints NewsOriginal article
Try first, evaluate later: How the FDA is approaching digital health devices
RegulatoryNeutral
AI Analysis
Summary
The FDA is selecting participants for its TEMPO pilot program on digital health devices, with Limbic joining previously announced participants Cadence and Dexcom. The article discusses the FDA's approach to evaluating digital health devices through this pilot initiative.
Importance:3/10
Sentiment:
0.00
digital healthFDA pilot programTEMPOremote monitoringbehavioral health
Related Companies
Read the original article
Published by Endpoints News on August 20, 2026 2:34 PM
